This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ejegod, D.
Right arrow Articles by Pedersen, F. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ejegod, D.
Right arrow Articles by Pedersen, F. S.

 Previous Article  |  Next Article 

Journal of Virology, January 2009, p. 336-346, Vol. 83, No. 1
0022-538X/09/$08.00+0     doi:10.1128/JVI.01368-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Control of Pathogenicity and Disease Specificity of a T-Lymphomagenic Gammaretrovirus by E-Box Motifs but Not by an Overlapping Glucocorticoid Response Element{triangledown}

Ditte Ejegod,1 Karina Dalsgaard Sørensen,1 Ilona Mossbrugger,2 Leticia Quintanilla-Martinez,2 Jörg Schmidt,3 and Finn Skou Pedersen1*

Department of Molecular Biology, University of Aarhus, Denmark,1 Institute of Pathology,2 Department of Comparative Medicine, Helmholtz Zentrum Munich, German Research Center for Environmental Health (GmbH), Neuherberg, Germany3

Received 1 July 2008/ Accepted 13 October 2008

Although transcription factors of the basic helix-loop-helix family have been shown to regulate enhancers of lymphomagenic gammaretroviruses through E-box motifs, the overlap of an E-box motif (Egre) with the glucocorticoid response element (GRE) has obscured their function in vivo. We report here that Egre, but not the GRE, affects disease induction by the murine T-lymphomagenic SL3-3 virus. Mutating all three copies of Egre prolonged the tumor latency period from 60 to 109 days. Further mutating an E-box motif (Ea/s) outside the enhancer prolonged the latency period to 180 days, suggesting that Ea/s works as a backup site for Egre. While wild-type SL3-3 and GRE and Ea/s mutants exclusively induced T-cell lymphomas with wild-type latencies mainly of the CD4+ CD8 phenotype, Egre as well as the Egre and Ea/s mutants induced B-cell lymphomas and myeloid leukemia in addition to T-cell lymphomas. T-cell lymphomas induced by the two Egre mutants had the same phenotype as those induced by wild-type SL3-3, indicating the incomplete disruption of T-cell lymphomagenesis, which is in contrast to previous findings for a Runx site mutant of SL3-3. Mutating the Egre site or Egre and Ea/s triggered several tumor phenotype-associated secondary enhancer changes encompassing neighboring sites, none of which led to the regeneration of an E-box motif. Taken together, our results demonstrate a role for the E-box but not the GRE in T lymphomagenesis by SL3-3, unveil an inherent broader disease specificity of the virus, and strengthen the notion of selection for more potent enhancer variants of mutated viruses during tumor development.


* Corresponding author. Mailing address: Department of Molecular Biology, University of Aarhus, C. F. Møllers Alle, bldg. 130, DK-8000 Aarhus, Denmark. Phone: 4589422614. Fax: 4586196500. E-mail: fsp{at}mb.au.dk

{triangledown} Published ahead of print on 22 October 2008.


Journal of Virology, January 2009, p. 336-346, Vol. 83, No. 1
0022-538X/09/$08.00+0     doi:10.1128/JVI.01368-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Dabrowska, M. J., Dybkaer, K., Johnsen, H. E., Wang, B., Wabl, M., Pedersen, F. S. (2009). Loss of MicroRNA Targets in the 3' Untranslated Region as a Mechanism of Retroviral Insertional Activation of Growth Factor Independence 1. J. Virol. 83: 8051-8061 [Abstract] [Full Text]